Most sickle cell disease patients who received the gene-editing therapy Casgevy have been free from vaso-occlusive crises for ...

Heart attacks are a leading cause of death and disability in Europe, and their effects often extend beyond the initial event, leading to chronic heart failure.

November 2024 has seen a variety of biotech deals take place to advance therapies across different stages in development.

Other news stories cover once-a-year HIV prevention shots, gene therapy to reverse heart failure, and more. A bipartisan coalition of US lawmakers has drafted legislation that would force prescription ...

Research led by Christian Medical College in Vellore, India, has demonstrated the successful use of lentiviral vectors to ...

A new study using gene therapy from the University of Utah reversed the impact of heart failure in pigs. Can it work on ...

Researchers found a genetic therapy that could be used to reverse heart failure. A recent study found that it worked on large ...

Investigators who previously found that a daily statin pill helps prevent heart attacks and strokes in people with HIV have now discovered a potential mechanism that may help to stabilize plaques and ...

Researchers at the meeting reported on long-term activity of commercialized gene therapies and preliminary data on ...

Heart failure has historically been irreversible, but a new study suggests that could change. At the University of Utah, ...

Avidity Biosciences' AOC platform shows promising results for genetic diseases, making it a strong buy with potential upside ...

Researchers suggest an application to FDA may be made within the next 12 months, requesting approval to carry out a human clinical trial with the gene therapy.